sulfasymazine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
anti-infectives, sulfonamides 3836 1984-94-7

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • sulfasymazine
  • prosymasul
  • sulphsymazine
  • symasul
  • Molecular weight: 307.37
  • Formula: C13H17N5O2S
  • CLOGP: 1.29
  • LIPINSKI: 0
  • HAC: 7
  • HDO: 2
  • TPSA: 110.86
  • ALOGS: -3.03
  • ROTB: 4

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
azlogd74 LogD at pH 7.4 -0.561 Moderate 0.68
caco2-efflux Caco-2 efflux ratio (BA/AB) 5.176 Moderate 0.68
caco2-intrinsic-papp Caco-2 intrinsic apparent permeability 7.145 10^-6 cm/s Moderate 0.68
dh-clint Dog hepatocyte intrinsic clearance 1.334 uL/min/10^6 cells Moderate 0.68
dppb Dog plasma protein binding (% unbound) 29.710 % Moderate 0.68
fcs-ppb Fetal calf serum protein binding (% unbound) 33.590 % Moderate 0.68
herg hERG pIC50 3.958 pIC50 Moderate 0.68
hh-clint Human hepatocyte intrinsic clearance 1.014 uL/min/10^6 cells Moderate 0.68
hlm-clint Human liver microsomal intrinsic clearance 3.162 uL/min/mg protein Moderate 0.68
hppb Human plasma protein binding (% unbound) 18.530 % Moderate 0.68
mdck-mdr1-efflux MDCK-MDR1 efflux ratio 4.898 Moderate 0.68
mh-clint Mouse hepatocyte intrinsic clearance 4.140 Moderate 0.68
mppb Mouse plasma protein binding (% unbound) 33.230 Moderate 0.68
nih-mdck-mdr1-efflux NIH MDCK-MDR1 efflux ratio 2.773 Moderate 0.68
pfas-class PFAS structural alert (1 = True, 0 = False) 0
pppb Pig plasma protein binding (% unbound) 28.100 % Moderate 0.68
rh-clint Rat hepatocyte intrinsic clearance 0.927 uL/min/10^6 cells Moderate 0.68
rh-fuinc Rat hepatocyte fraction unbound in incubation 91.830 % Moderate 0.68
rppb Rat plasma protein binding (% unbound) 12.280 % Moderate 0.68
solubility-dd Solubility at pH 7.4 in DMSO 995.405 uM Moderate 0.68

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
MeSH PA D000890 Anti-Infective Agents

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 7.91 acidic
pKa2 3.42 Basic
pKa3 1.91 Basic
pKa4 0.82 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
C0075526 UMLSCUI
CHEBI:135305 CHEBI
CHEMBL2107230 ChEMBL_ID
C005744 MESH_SUPPLEMENTAL_RECORD_UI
16132 PUBCHEM_CID
1097 INN_ID
ZZZ3BU4OA7 UNII

Pharmaceutical products:

None